This is a partitioner-only product. Purchasing this product/supplement requires either:

  • A complimentary phone consultation by us to discuss your needs and determine whether this product is suitable for you; or

  • A script or referral documentation from a qualified health professional.

  • Skip to product information
    1 of 4


    TocoCare 30 Capsules- Metagenics

    TocoCare 30 Capsules- Metagenics

    Tax included. Shipping calculated at checkout.

    ➤ Don't have a password yet?

    TocoCare 30 Capsules in New Zealand

    Citrus Bioflavonoids And Tocotrienols Complex.

    In healthy people, ingredients in TocoCare have been shown to or may:

    • Help maintain healthy total cholesterol levels.
    • Improve LDL:HDL ratio by 26% in four weeks.
    • Clinically trialled, once daily dose.


    Clinical Benefits:

    • The combination of 270 mg of citrus bioflavonoids (PMF-source™) and 18 mg of tocotrienols (TocoSource™), has been shown to impact total cholesterol by an average of 25% over 4 weeks and 27% over 12 weeks: Three studies including a double blind, randomised clinical trial plus two open-label trials demonstrated significant reductions in total cholesterol, triglycerides and LDL:HDL ratio (Figure One).


    Figure One: Citrus Bioflavonoids and Tocotrienol Combination Impact Cholesterol in a Clinical Trial with 120 subjects.


    • Key mechanisms include HMG-CoA reductase inhibition, reduction of apolipoprotein-B100 secretion and modulation of hepatic LDL receptors. Specifically, the polymethoxyflavones tangeretin and nobiletin, suppress the hepatic secretion of ApoB and increase LDL receptor synthesis. PMF-source™ is an exclusive extract of citrus bioflavonoids containing at least 11.5 mg of tangeretin and 10 mg nobiletin per dose.


    Figure Two: Ingredients in CholCare act upon multiple points within the Mevalonate Pathway.


    • TocoSource™ tocotrienols inhibit the production of HMGCoA reductase but support endogenous CoQ10 production via induction of the enzyme geranylgeranyl pyrophosphate (GGPP). In vitro research shows an 80% inhibition of HMG-CoA reductase by decreasing transcription efficiency and enhancing degradation, unlike most HMG-CoA reductase inhibitors which block the mevalonate pathway by up to 99%.



    Adults: Take 1 capsule at night.



    Store below 30° C


    *Sustainably sourced palm.

    Pack: 30 Capsules
    View full details